|
|
||||||||||||||
|
|
|||||||||||||||
SPECIAL COMMUNICATION |
Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
Correspondence to:
N Gray
Division of Epidemiology and Biostatistics, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy; nigel{at}uicc.ch
The cigarette usually carries in its smoke significant doses of carcinogenic tobacco specific nitrosamines (TSNAs), which have been implicated as causes of oral, lung, oesophageal, and pancreatic cancer. However, there is substantial variation in nitrosamine content of the smoke of modern cigarettes. This variation is both unacceptable and unnecessary, as TSNAs can be readily removed during the manufacturing process. Removing a known carcinogen needs no justification, even though proof of benefit may not be forthcoming for decades.
Keywords: tobacco specific nitrosamines; TSNA
Abbreviations: ISO, International Standard Organisation; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; TSNAs, tobacco specific nitrosamines
This article has been cited by other articles:
![]() |
N. Gray The consequences of the unregulated cigarette. Tob. Control, October 1, 2006; 15(5): 405 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Chapman Research from tobacco industry affiliated authors: need for particular vigilance Tob. Control, August 1, 2005; 14(4): 217 - 219. [Full Text] [PDF] |
||||
![]() |
W A Farone Accepting premature deaths from smoking Tob. Control, March 1, 2004; 13(1): 1 - 2. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |